Cambridge Healthtech Institute’s 13th Annual

Antibodies for Cancer Therapy

Driving Breakthrough Therapies

May 15-16, 2023

 

The success of monoclonal antibodies as a therapeutic class for cancer has given rise to the development of various types of therapeutic antibodies, including antibody fragments/scaffolds, bispecific/multispecific antibodies, antibody-drug conjugates, immunocytokines etc. At the same time, cell-based therapy has emerged as a promising immunotherapy approach to cancer. The Antibodies for Cancer Therapy conference aims to showcase the latest and hottest in these therapeutic approaches, inviting speakers to discuss their mechanisms, engineering, preclinical to clinical translation, and combination strategies.

 

Coverage will include, but is not limited to:

 

  • Antibodies in Development
    • T cell redirected antibodies
    • Bispecifics/biparatopic antibodies
    • Antibody-drug conjugates
    • Agonistic antibodies
    • NBE-based degraders
    • Recombinant immunotoxins
    • Therapeutic cancer vaccines

       

  • Trending Cell-Based Approaches
    • CAR-M
    • Engineered CAR-T/NK based approaches
    • RNA/DNA/AAV delivered antibodies
    • Immunocytokines

       

  • Combination Therapies
    • Combination strategies
    • Combinations with checkpoint inhibitors
    • Toxicities and independent drug action in combination therapies

 

The deadline for priority consideration is October 21, 2022.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

 

Opportunities for Participation:

 

 

For more details on the conference, please contact:

Mimi Langley

Senior Conference Director

Cambridge Healthtech Institute

Phone: 781-972-5439

Email: mlangley@healthtech.com

 

For sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-5452

Email: jgerardi@healthtech.com

 

Companies L-Z

Ashley Parsons

Manager, Business Development

Cambridge Healthtech Institute

Phone: 781-972-1340

Email: ashleyparsons@healthtech.com